3Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol, 2005,6 (6) : 401-410.
4Umeadi C, Kandeel F, Al-Abdullah IH. Ulinastatin is a novel protease inhibitor and neutral protease activator. Transplant Proc,2008,40(2) :387-389.
5Macellari F, Paciaroni M, Agnelli G, et al. Perioperative stroke risk in nonvascular surgery. Cerebrovasc Dis, 2012, 34(3): 175-181.
6Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Inflam?mation in ischemic stroke subtypes. Curr Pharm Des, 2012, 18(28) :4289-4310.
7Wannamethee SG, Whincup PH, Lennon L, et al. Fibrin D?dimer , tissue-type plas minogen activator, von Willebrand factor, and risk of incident stroke in older men. Stroke, 2012,43(5):1206-1211.
8Corrado E. Rizzo M. Muratori I, et al. Older age and mark?ers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. Menopause. 2008.15(2) :240-247.
9Wu CH. Yang RL. Huang SY. et al. Analysis of thrombin?antithrombin complex contents in plasma and hematoma fluid of hypertensive intracerebral hemorrhage patients after clot removal. EurJ Neurol , 2011.18(8): 1060-1066.
10Chiu CC. Li YN. Lin LJ. et al. Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage.J Clin Neurosci , 2012. 19(6): 810-813.
